Scarica l'app Stockscreener
2.00
1.52%
0.03
Dopo l'orario di chiusura:
2.01
0.010
+0.50%
Precedente Chiudi:
$1.97
Aprire:
$1.99
Volume 24 ore:
2.92M
Relative Volume:
1.96
Capitalizzazione di mercato:
$139.02M
Reddito:
-
Utile/perdita netta:
$-117.50M
Rapporto P/E:
-0.8333
EPS:
-2.4
Flusso di cassa netto:
$-114.31M
1 W Prestazione:
+33.33%
1M Prestazione:
+14.29%
6M Prestazione:
-55.75%
1 anno Prestazione:
-81.50%
Intervallo 1D:
$1.92
$2.12
Intervallo di 1 settimana:
$1.31
$2.34
Portata 52W:
$1.31
$11.84
Nkarta Inc Stock (NKTX) Company Profile
Nome
Nkarta Inc
Settore
Industria
Telefono
(925) 407-1049
Indirizzo
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO
Confronta NKTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NKTX
Nkarta Inc
|
2.00 | 139.02M | 0 | -117.50M | -114.31M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Nkarta Inc Stock (NKTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-09 | Iniziato | Rodman & Renshaw | Buy |
| 2024-08-14 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2022-12-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-10-10 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-28 | Iniziato | Needham | Buy |
| 2022-07-18 | Iniziato | SVB Leerink | Outperform |
| 2022-03-11 | Iniziato | Raymond James | Outperform |
| 2022-03-08 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-06 | Iniziato | William Blair | Outperform |
| 2021-11-18 | Iniziato | SMBC Nikko | Outperform |
| 2021-07-16 | Iniziato | Oppenheimer | Outperform |
| 2020-08-04 | Iniziato | Cowen | Outperform |
| 2020-08-04 | Iniziato | Evercore ISI | Outperform |
| 2020-08-04 | Iniziato | Mizuho | Buy |
| 2020-08-04 | Iniziato | Stifel | Buy |
Mostra tutto
Nkarta Inc Borsa (NKTX) Ultime notizie
Nkarta, Inc. (NASDAQ:NKTX) Receives $14.86 Average Price Target from Brokerages - Defense World
Stifel Nicolaus Has Lowered Expectations for Nkarta (NASDAQ:NKTX) Stock Price - Defense World
HC Wainwright Reiterates Buy Rating for Nkarta (NASDAQ:NKTX) - Defense World
Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace
Nkarta’s Strategic Workforce Reduction and Clinical Progress Justify Buy Rating - TipRanks
Analysts Adjust Price Targets For Nkarta And Bicara - Evrim Ağacı
Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? - Benzinga
Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy - BioPharma Dive
Stifel cuts Nkarta stock price target to $14, maintains buy rating - Investing.com India
Nkarta to lay off 34% of staff; Savara’s debt financing deal - Endpoints News
H.C. Wainwright maintains Buy on Nkarta stock with $18 target - Investing.com
Nkarta lays off 3rd of staff to fund autoimmune CAR NK program - Fierce Biotech
Newly pivoted to autoimmune, Nkarta trims staff by over third - FirstWord Pharma
Nkarta’s Strategic Restructuring and NKX019 Progress Drive Buy Rating - TipRanks
Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - GlobeNewswire
Nkarta Posts Narrower Q4 Loss; Discloses Restructuring Plan - Marketscreener.com
Nkarta Announces Major Restructuring and Leadership Changes - TipRanks
Nkarta Inc To Reduce Workforce By 34%, Impacting 53 PositionsSEC Filing - Marketscreener.com
Nkarta Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month - MSN
Nkarta (NKTX) Loses -33.62% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Nkarta (NKTX) Loses -32.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Nkarta Inc expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Nkarta (NKTX) Projected to Post Earnings on Thursday - Defense World
NKTX stock touches 52-week low at $1.69 amid market challenges - Investing.com
Comparing Tempest Therapeutics (NASDAQ:TPST) & Nkarta (NASDAQ:NKTX) - Defense World
Will Nkarta (NASDAQ:NKTX) Spend Its Cash Wisely? - Simply Wall St
Nkarta to Participate in March Investor Conferences - The Manila Times
NKTX stock touches 52-week low at $1.96 amid market challenges - Investing.com
Leerink Partnrs Forecasts Nkarta FY2029 Earnings - MarketBeat
Leerink Partnrs Comments on Nkarta FY2024 Earnings - Defense World
Leerink Partnrs Comments on Nkarta FY2029 Earnings - Defense World
Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Stock Performance Spotlight: Nkarta Inc (NKTX) Ends the Day at 2.09, Down by -3.69 - The Dwinnex
Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Rating of “Buy” by Brokerages - Defense World
A new trading data show Nkarta Inc (NKTX) is showing positive returns. - SETE News
Vasculitis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | R-Pharm Overseas, Abbvie, Toleranzia, Ambulero, Visterra, CytoDyn - The Globe and Mail
Monitoring Nkarta Inc (NKTX) after recent insider movements - Knox Daily
The Potential Rise in the Price of Trane Technologies plc (TT) following insiders activity - Knox Daily
Closing Figures: Nkarta Inc (NKTX)’s Negative Finish at 2.17, Down -7.26 - The Dwinnex
TANG CAPITAL MANAGEMENT LLC Increases Stake in Nkarta Inc - GuruFocus.com
What Does Nkarta Inc’s (NASDAQ: NKTX) Future Hold? - Stocks Register
Nkarta's chief medical officer sells $19,003 in stock - MSN
Nkarta CEO Paul Hastings sells $38,231 in stock - MSN
Nkarta executive sells shares worth $12,843 - MSN
Nkarta's chief technical officer sells $16,383 in stock By Investing.com - Investing.com Australia
Nkarta chief legal officer Alicia Hager sells $21,084 in stock - Investing.com India
Nkarta chief legal officer Alicia Hager sells $21,084 in stock By Investing.com - Investing.com Australia
Nkarta Inc Azioni (NKTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):